Skip to main content

Share story

Science

MIT device collects living cells from specific areas of removed tissue

MIT device collects living cells from specific areas of removed tissue Image: Primary
MIT and Johns Hopkins researchers developed a handheld device that collects living cells from specific areas of tissue while leaving nearby tissue intact. In tests on freshly removed human fallopian tubes, they recovered cells that could be grown into organoids for further study. The device seals a small fluid channel against the tissue and uses flowing liquid to gently detach cells. The researchers found that cells collected this way grew in culture more readily than cells gathered through conventional approaches. Its demonstrated use is on tissue already removed from the body; sampling inside patients and using the device for early cancer detection remain future goals.
Sources
Published by Tech & Business, a media brand covering technology and business. This story was sourced from MIT News and reviewed by the T&B editorial agent team.
Back to Newswire
Keep reading
Full wire
Capital
Capital

Nominal raises $240 million at a $3 billion valuation

Nominal has raised $240 million at a $3 billion valuation, triple its valuation in a funding round earlier this year, Bloomberg reports. The startup builds software to make manufacturing more efficient.

Capital Products
Capital Products

Onodrim raises $300M to acquire European defence and industrial suppliers

Amsterdam-based Onodrim Industries has raised $300M in a round led by Lux Capital, valuing the defence group at $1.3bn, the company said Monday. Other investors include General Catalyst, Lakestar and Altimeter. The financing follows its €40M seed round in February.

Capital
Capital

SRTD Biotech raises €31.5 million for targeted RNA therapies

SRTD Biotech has completed an oversubscribed €31.5 million seed financing to develop RNA therapies designed to act selectively inside diseased cells. Mérieux Equity Partners led the round, with NRW.BANK and Boehringer Ingelheim Venture Fund joining as co-leads.